Cholesterol efflux alters lipid raft stability and distribution during capacitation of boar spermatozoa.
A reduction in plasma membrane cholesterol is one of the early events that either triggers or is closely associated with capacitation of mammalian spermatozoa. In this investigation, we have examined the effects of cholesterol efflux on tyrosine phosphorylation, lipid diffusion, and raft organization in boar spermatozoa. Results show that a low level of cholesterol efflux, mediated by 5 mM methyl-beta-cyclodextrin (MBCD), enhances capacitation and induces phosphorylation of two proteins at 26 and 15 kDa without affecting sperm viability. Lipid diffusion rates under these conditions are largely unaffected except when cholesterol efflux is excessive. Low-density Triton X100-insoluble complexes (lipid rafts) were isolated from spermatozoa and found to have a restricted profile of proteins. Capacitation-associated cholesterol efflux has no effect on raft composition, but cholesterol depletion destabilizes them completely and phosphorylation is suppressed. During MBCD-mediated capacitation, the distribution of GM1 gangliosides on spermatozoa changes in a sequential manner from overlying the sperm tail to clustering on the sperm head. It is concluded that there is a safe window for removal of plasma membrane cholesterol from spermatozoa within which protein phosphorylation and polarized migration of lipid rafts take place. A preferential loss of cholesterol from the nonraft pool may be the stimulus that promotes raft clustering over the anterior sperm head.
Shadan
Sadaf
S
Gamete Signalling Laboratory, Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom.
James
Peter S
PS
Howes
Elizabeth A
EA
Jones
Roy
R
D020101:Acrosome Reaction / Q000187:drug effects; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002751:Chlortetracycline; D002784:Cholesterol / Q000378:metabolism*; D004058:Diffusion; D005677:G(M1) Ganglioside / Q000378:metabolism; D007476:Ionophores / Q000494:pharmacology; D050356:Lipid Metabolism; D008297:Male; D021962:Membrane Microdomains / Q000502:physiology*; D010766:Phosphorylation / Q000187:drug effects; D011506:Proteins / Q000378:metabolism; D013075:Sperm Capacitation / Q000502:physiology*; D013091:Spermatogenesis / Q000502:physiology; D013094:Spermatozoa / Q000187:drug effects / Q000502:physiology*; D013108:Sphingomyelin Phosphodiesterase / Q000494:pharmacology; D013194:Staining and Labeling; D013552:Swine; D014018:Tissue Distribution; D014443:Tyrosine / Q000378:metabolism; D047392:beta-Cyclodextrins / Q000494:pharmacology
D007476:Ionophores; D011506:Proteins; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D005677:G(M1) Ganglioside; D014443:Tyrosine; D002784:Cholesterol; D013108:Sphingomyelin Phosphodiesterase; D002118:Calcium; D002751:Chlortetracycline